Cannabioxepane, a Novel Tetracyclic Cannabinoid from Hemp, Cannabis sativa L.

  title={Cannabioxepane, a Novel Tetracyclic Cannabinoid from Hemp, Cannabis sativa L.},
  author={Alberto Pagani and Fernando Scala and Giuseppina Chianese and Gianpaolo Grassi and Giovanni Appendino and Orazio Taglialatela‐Scafati},
isolation and structure elucidation of cannabioxepane (I), which does not show cannabinoid activity, and isocannabispiradienone (II) 
Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis
This review discusses the chemistry of the cannabinoids and major non-cannabinoid constituents (terpenes, non-Cannabinoid phenolics, and alkaloids) with special emphasis on their chemical structures, methods of isolation, and identification.
Phytochemistry of Cannabis sativa L.
This contribution presents an overview of the botany, cultivation aspects, and the phytochemistry of cannabis and its chemical constituents, with particular emphasis on the newly-identified/isolated compounds.
In vitro cholinesterase inhibitory action of Cannabis sativa L. Cannabaceae and in silico study of its selected phytocompounds
This study not only approved cholinesterase inhibitory effects of cannabis but also suggested an array of phytocompounds as hit small molecules for discovery or design of ecofriendly botanical antiinsectants or phytonootropic drugs.
The pharmacological properties of cannabis
This chapter reviews the general structure of cannabinoids, the current understanding of cannabinoids on cellular systems, the difference between inhalation and oral consumption on cannabinoid bioavailability, the variance among purified cannabinoids versus whole plant extract, and the potential activities of another prominent family of secondary metabolites found in cannabis, the terpenes.
Metabolomics and bioanalysis of terpenoid derived secondary metabolites
This thesis provides the basis for recombinant cannabinoid production by providing screening techniques for cannabinoid profiling and insights into the mechanism of cannabinoid precursor production.
Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
This review summarises the lengthy history of Cannabis and details the molecular pathways that underpin the production of key secondary metabolites that may confer medical efficacy, and explores additional avenues for the potential improvement of the medical potential of the Cannabis plant.
Extraction of Phenolic Compounds and Terpenes from Cannabis sativa L. By-Products: From Conventional to Intensified Processes
A thorough investigation of innovative extraction techniques is indeed crucial for the extraction of phenolic compounds and terpenes from cannabis toward a sustainable industrial valorization of the whole plant.
Phytocannabinoids: a unified critical inventory.
The integrated inventory of these compounds and their biological macromolecular end-points highlights the opportunities that phytocannabinoids offer to access desirable drug-like space beyond the one associated to the narcotic target CB1.